prednisolone has been researched along with Latent Tuberculosis in 8 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 66-year-old woman with seropositive rheumatoid arthritis (RA) and latent tuberculosis infection developed minimal-change nephrotic syndrome following the initiation of anti-tuberculosis chemoprophylaxis with isoniazid." | 7.77 | Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis. ( Arizono, K; Matsushita, Y; Mori, S, 2011) |
| "Prednisolone treatment was strongly associated with negative TST, adjusted odds ratio (AOR) 0." | 5.37 | Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. ( Bélard, E; Brylov, A; Hetland, ML; Jensen, FK; Nordgaard-Lassen, I; Ravn, P; Ruhwald, M; Semb, S; Soborg, B; Thomsen, H; Werlinrud, AM, 2011) |
| "Here, we report a 51-year-old woman with latent tuberculosis infection who developed nephrotic syndrome during treatment with rifampicin and isoniazid for 25 days." | 3.88 | Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report. ( Choi, EY; Kim, JS; Kim, KJ, 2018) |
| "A 66-year-old woman with seropositive rheumatoid arthritis (RA) and latent tuberculosis infection developed minimal-change nephrotic syndrome following the initiation of anti-tuberculosis chemoprophylaxis with isoniazid." | 3.77 | Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis. ( Arizono, K; Matsushita, Y; Mori, S, 2011) |
| "Isoniazid was prescribed to 684 (66." | 1.72 | Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates. ( Borekci, S; Celik, AF; Esatoglu, SN; Fresko, I; Hacioglu, A; Hamuryudan, V; Hatemi, G; Hatemi, I; Melikoglu, M; Ongen, HG; Ozdogan, H; Ozguler, Y; Seyahi, E; Ugurlu, S; Yurdakul, S, 2022) |
| "Prednisolone treatment was strongly associated with negative TST, adjusted odds ratio (AOR) 0." | 1.37 | Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. ( Bélard, E; Brylov, A; Hetland, ML; Jensen, FK; Nordgaard-Lassen, I; Ravn, P; Ruhwald, M; Semb, S; Soborg, B; Thomsen, H; Werlinrud, AM, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chew, R | 1 |
| Woods, ML | 1 |
| Itagaki, M | 1 |
| Iketani, O | 1 |
| Enoki, Y | 1 |
| Chuang, VTG | 1 |
| Taguchi, K | 1 |
| Uno, S | 1 |
| Uchida, S | 1 |
| Namkoong, H | 1 |
| Uwamino, Y | 1 |
| Takano, Y | 1 |
| Hasegawa, N | 1 |
| Matsumoto, K | 1 |
| Hansen, KC | 1 |
| Jensen-Fangel, S | 1 |
| Hønge, BL | 1 |
| Hacioglu, A | 1 |
| Borekci, S | 1 |
| Melikoglu, M | 1 |
| Ozguler, Y | 1 |
| Esatoglu, SN | 1 |
| Ugurlu, S | 1 |
| Seyahi, E | 1 |
| Fresko, I | 1 |
| Hamuryudan, V | 1 |
| Ozdogan, H | 1 |
| Yurdakul, S | 1 |
| Hatemi, I | 1 |
| Celik, AF | 1 |
| Ongen, HG | 1 |
| Hatemi, G | 1 |
| Kim, JS | 1 |
| Kim, KJ | 1 |
| Choi, EY | 1 |
| Mori, S | 1 |
| Matsushita, Y | 1 |
| Arizono, K | 1 |
| Bélard, E | 1 |
| Semb, S | 1 |
| Ruhwald, M | 1 |
| Werlinrud, AM | 1 |
| Soborg, B | 1 |
| Jensen, FK | 1 |
| Thomsen, H | 1 |
| Brylov, A | 1 |
| Hetland, ML | 1 |
| Nordgaard-Lassen, I | 1 |
| Ravn, P | 1 |
| Campainha, S | 1 |
| Gomes, T | 1 |
| Carvalho, A | 1 |
| Duarte, R | 1 |
8 other studies available for prednisolone and Latent Tuberculosis
| Article | Year |
|---|---|
Multibacillary Mid-Borderline Leprosy with Type 1 Lepra Reaction and Concurrent Latent Tuberculosis.
Topics: Abattoirs; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Dapsone; Diagnosis, Differe | 2021 |
Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications.
Topics: Biological Products; Humans; Latent Tuberculosis; Prednisolone; Retrospective Studies; Risk Factors; | 2023 |
Contribution to differential diagnosis of sarcoidosis and disseminated tuberculosis.
Topics: Antimalarials; Diagnosis, Differential; Humans; Latent Tuberculosis; Male; Medical History Taking; M | 2019 |
Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates.
Topics: Adult; Azathioprine; BCG Vaccine; Humans; Isoniazid; Latent Tuberculosis; Male; Prednisolone; Reprod | 2022 |
Minimal change disease related to rifampicin presenting with acute renal failure during treatment for latent tuberculosis infection: A case report.
Topics: Acute Kidney Injury; Antitubercular Agents; Female; Glucocorticoids; Humans; Isoniazid; Latent Tuber | 2018 |
Minimal-change nephrotic syndrome associated with isoniazid in anti-tuberculosis chemoprophylaxis for a patient with rheumatoid arthritis.
Topics: Aged; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Chemoprevention; Comorbidi | 2011 |
Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cohor | 2011 |
Negative predictive value of TST and IGRA in anti-TNF treated patients.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Drug Therapy, Combination; Femal | 2012 |